Authors
Latest:
2019 ASCCP guidelines: Pearls for practitionersConsensus group discussion resulted in a shift from results-based to risk-based management for cervical cancer screening.
Latest:
Breaking: FDA approves, authorizes updated monovalent COVID-19 vaccinesBivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.
Latest:
HPV vaccine rates rise in teens when they can consent, research showsState legislation that allows adolescents to choose to receive the HPV vaccine without parental interference would elevate immunization rates, according to a new study.
Latest:
Current choices in cervical cancer screeningIt is essential to expand access to all available, effective cervical cancer screening options for the most vulnerable populations. The targeted use of any particular screening modality in higher-risk populations is not supported by evidence-based guidelines; any effective screening is the priority.
Latest:
Iron-deficiency anemia in pregnancy and the role of intravenous ironAnemia in pregnancy should be treated due to its connection to adverse maternal and neonatal outcomes.
Latest:
Web-based tool for family cancer history information collectionIn an interview with Targeted Oncology, Melissa K. Frey, MD, discussed findings from implementing web-based health information collection of family history in patients with gynecologic cancers.
Latest:
Surgical treatments for endometriosisLaparoscopy remains the gold standard for diagnosis and treatment of the disease.
Latest:
IVIG safe, effective for treating pregnant patients with severe COVID-19Intravenous immunoglobulin shows promise as a treatment option for pregnant patients with SARS-CoV-2, influenza, and other respiratory viruses.
Latest:
Deep dive into fetal ventriculomegalyFetal ventriculomegaly, a condition marked by the dilation of cerebral ventricles, is a common finding on second-trimester ultrasounds and requires careful evaluation to determine its causes, severity, and potential impact on neurological outcomes.
Latest:
A noninfectious “infection” after cesarean deliveryExperts evaluate 3 clinical scenarios and determine the appropriate course of action.
Latest:
A noninfectious “infection” after cesarean deliveryExperts evaluate 3 clinical scenarios and determine the appropriate course of action.
Latest:
From data to wisdomLeveraging the DIKW pyramid, SOAP notes, and teamwork for practice efficiency and performance improvement.
Latest:
Violence against women and acquired brain injuriesViolence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.
Latest:
Endometrial ablation in the office settingBreaking down barriers through patient selection, new devices, and the latest techniques.
Latest:
An update on the presentation, nosology, and causes of postpartum psychosisPostpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.
Latest:
SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidyIn this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.
Latest:
Diagnosis and Management of Gestational DiabetesWhat every OB/GYN needs to know to manage this complication.
Latest:
COVID-19's impact on patient portal utilization and disparitiesA recent study analyzing patient portal use amidst the COVID-19 pandemic unveils changes in sociodemographic trends and disparities, highlighting shifts in user behavior and access challenges.
Latest:
FDA approves dostarlimab for dMMR endometrial cancerThe FDA has granted a regular approval to dostarlimab-gxly (Jemperli; GSK) for adult patients with mismatch repair–deficient, recurrent or advanced endometrial cancer that has progressed on or after a prior platinum-containing regimen in any setting and who are not candidates for curative surgery or radiation.
Latest:
SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidyIn this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.
Latest:
Combined hormonal contraceptives merit risk assessment in patients with obesityCombined hormonal contraceptives such as the combined oral contraceptive pill, the patch, and the vaginal ring each have unique considerations for use in patients with obesity.
Latest:
Niraparib Demonstrates PFS Benefit in Chinese Population With Advanced Ovarian CancerFirst-line maintenance treatment with the PARP inhibitor niraparib yielded a clinically meaningful and statistically significant improvement in progression-free survival vs placebo in Chinese patients with platinum-responsive advanced ovarian cancer, regardless of biomarker status, according to data from the phase 3 PRIME trial.
Latest:
Treatment validation platforms can reduce care variations and promote health equityEmerging technology helps ensure best practices while reducing costs of care.
Latest:
Clues to the origins of ovarian cancerFamily history assessment, genetic screening are key to prevention.
Latest:
Statin use in midlife womenRisk assessment, lifestyle counseling, adverse effects, and medication management.
Latest:
Helping parents cope with adolescent behaviorA teenager’s day-to-day behavior can vary greatly. Here are some tips for understanding and navigating this challenging time.
Latest:
Uterine anomalies in pregnancyClinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.
Latest:
Bladder health monthReview bladder disorders and management methods you can discuss with your patients.
